Aethlon Medical (AEMD) Equity Average (2011 - 2026)

Aethlon Medical's Equity Average history runs 16 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 22.64% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 22.64% YoY), and the FY2026 full-year result was $5.0 million, down 8.08% from the prior year.
• Equity Average was $5.8 million for Q1 2026 at Aethlon Medical, down from $6.2 million in the prior quarter.
• Over the last five years, Equity Average for AEMD reached as high as $18.8 million in Q1 2022 and fell as low as $4.3 million in Q2 2025.
• Median Equity Average over the past 5 years was $7.4 million (2024), compared with a mean of $10.2 million.
• Across the five-year window, Equity Average jumped 81.16% in 2022 and slumped 58.64% in 2024, its largest moves.
• Over 5 years, Equity Average stood at $18.6 million in 2022, then slumped by 51.73% to $9.0 million in 2023, then plunged by 42.26% to $5.2 million in 2024, then gained by 20.34% to $6.2 million in 2025, then fell by 6.9% to $5.8 million in 2026.
• Business Quant data shows AEMD's Equity Average at $5.8 million in Q1 2026, $6.2 million in Q4 2025, and $4.6 million in Q3 2025.